BATM Advanced Communications Ltd.

Regulatory Filings • Feb 27, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2670E

BATM Advanced Communications Ld

27 February 2020

LEI: 213800FLQUB9J289RU66

27 February 2020

BATM Advanced Communications Limited

("BATM" or "the Group")

BATM Develops Diagnostics Kit for COVID-19

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that its Bio-Medical division has successfully developed a new diagnostics kit to detect COVID-19. Additionally, this kit has undergone testing by several central laboratories and hospitals that have now verified its ability to diagnose COVID-19.

The Group has commenced production of the kit at its Adaltis facility in Rome. BATM is working with academic and research institutions, mainly in Europe, to progress the kit to make it at a price point suitable for large scale production. The kit, which supports all the Centers for Disease Control and Prevention (CDC) recommendations, has already received interest from customers in several countries.

In addition, COVID-19 will be included within the Ador suite of testing kits as part of its travel panels. Laboratory bench tests are expected to commence imminently.

Dr Zvi Marom, Chief Executive Officer of BATM, said:

"We believe that the strategy we adopted in our Bio-Medical division is proving to be correct, especially in light of the current COVID-19 outbreak. We are able now to quickly provide diagnostic kits for any new pathogen that appears.

"Furthermore, we have already received extremely positive feedback and significant interest from several leading medical institutions that have started testing the first panel of Ador's NATlab solution and adding COVID-19 will greatly strengthen its appeal and value."

Enquiries:

BATM Advanced Communications
Dr Zvi Marom, Chief Executive Officer	+972 9866 2525
Moti Nagar, Chief Financial Officer
Shore Capital
Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory) Henry Willcocks (Corporate Broking)	+44 20 7408 4050
Luther Pendragon
Harry Chathli, Claire Norbury, Rachel So	+44 20 7618 9100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCTFMPTMTITBLM